Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
UKRAINE – AbbVie has announced that all profits from its essential medicines sales in Russia will be donated to direct humanitarian relief efforts in Ukraine. AbbVie, along with Novartis and…
Read More
USA – AbbVie has announced that the FDA has expanded Rinvoq (upadacitinib) approval to include the treatment of adults with moderate-to-severely active ulcerative colitis (UC) who have had insufficient response…
Read More
USA – US pharma major AbbVie has again linked up with Hungary’s largest drugmaker Gedeon Richter in research, development, and marketing of new dopamine receptor modulators for the treatment of…
Read More
USA – AbbVie has expanded its neuropsychiatric and neurodegenerative portfolio with the US$1 billion acquisition of Belgium-based Syndesi Therapeutics. AbbVie will make an upfront payment of US$130 million to Syndesi…
Read More
SWITZERLAND – Two private equity giants are discussing launching a joint bid for Novartis’ generics unit, Bloomberg has reported. Novartis announced last year that it was conducting a strategic review…
Read More
SWITZERLAND – Roche announced that it has received FDA approval for the first-ever bispecific antibody treatment for two common causes of vision loss, paving the way for a battle with…
Read More
USA – Eli Lilly and Company has announced that it will invest more than US$1 billion in a new manufacturing facility in North Carolina. Eli Lilly’s new facility in Concord,…
Read More
USA – The FDA has approved two once-daily, oral JAK inhibitors on for patients with moderate-to-severe atopic dermatitis whose disease is not well controlled with other systemic medications, including biologics,…
Read More
FRANCE – ABL Biotechnologies, a South Korean biotechnology firm, has signed a global licensing and exclusive collaboration agreement with Sanofi to develop and commercialize a new Parkinson’s disease therapy candidate.…
Read More
INDIA – Sun Pharmaceuticals Industries announced that one of its wholly-owned subsidiaries received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA)…
Read More